A phenanthroline ligand has been covalently modified at the 2 and 9 positions by an aminophenylhexamolybdate substituent. The 1H NMR spectrum indicated a strong electron-withdrawing effect of the hexamolybdate (Mo6O19(2-)) moiety on the phenanthroline ligand. UV-vis and cyclic voltammetry showed extended conjugation of the hybrid phenanthroline-polyoxometalate compound and the possibility of easy oxidation of the extended phenanathroline ligand. Further EPR experiments provided strong evidence for an intramolecular charge-transfer process with the formation of a phenanthroline cation radical and a reduced hexamolybdate.
No takes yet. Share an insight, caveat, or question.
Bar-Nahum et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: